State Street’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20M | Buy |
87,334
+19,385
| +29% | +$4.35M | ﹤0.01% | 2236 |
|
|
2025
Q4 | $14.5M | Buy |
67,949
+6,411
| +10% | +$1.32M | ﹤0.01% | 2429 |
|
|
2025
Q3 | $12.2M | Buy |
61,538
+3,335
| +6% | +$622K | ﹤0.01% | 2528 |
|
|
2025
Q2 | $10M | Sell |
58,203
-8,576
| -13% | -$1.4M | ﹤0.01% | 2602 |
|
|
2025
Q1 | $10.4M | Sell |
66,779
-4,977
| -7% | -$711K | ﹤0.01% | 2506 |
|
|
2024
Q4 | $9.88M | Buy |
71,756
+297
| +0.4% | +$39K | ﹤0.01% | 2636 |
|
|
2024
Q3 | $10.7M | Buy |
71,459
+36,402
| +104% | +$4.92M | ﹤0.01% | 2559 |
|
|
2024
Q2 | $4.78M | Buy |
35,057
+705
| +2% | +$95.9K | ﹤0.01% | 2951 |
|
|
2024
Q1 | $5.19M | Buy |
34,352
+3,100
| +10% | +$442K | ﹤0.01% | 2910 |
|
|
2023
Q4 | $3.94M | Buy |
31,252
+525
| +2% | +$52.3K | ﹤0.01% | 3056 |
|
|
2023
Q3 | $2.88M | Sell |
30,727
-555
| -2% | -$51.9K | ﹤0.01% | 3171 |
|
|
2023
Q2 | $2.79M | Sell |
31,282
-27,800
| -47% | -$2.42M | ﹤0.01% | 3261 |
|
|
2023
Q1 | $6.33M | Sell |
59,082
-26,967
| -31% | -$3.09M | ﹤0.01% | 2893 |
|
|
2022
Q4 | $10.5M | Buy |
86,049
+61,429
| +250% | +$7.13M | ﹤0.01% | 2665 |
|
|
2022
Q3 | $2.54M | Buy |
24,620
+286
| +1% | +$27.1K | ﹤0.01% | 3340 |
|
|
2022
Q2 | $2.26M | Sell |
24,334
-15,720
| -39% | -$1.48M | ﹤0.01% | 3436 |
|
|
2022
Q1 | $4.7M | Buy |
40,054
+15,689
| +64% | +$1.82M | ﹤0.01% | 3209 |
|
|
2021
Q4 | $3.28M | Buy |
24,365
+2,352
| +11% | +$350K | ﹤0.01% | 3449 |
|
|
2021
Q3 | $3.51M | Sell |
22,013
-3,731
| -14% | -$511K | ﹤0.01% | 3413 |
|
|
2021
Q2 | $3.39M | Buy |
25,744
+1,827
| +8% | +$243K | ﹤0.01% | 3409 |
|
|
2021
Q1 | $3.08M | Buy |
23,917
+2,329
| +11% | +$354K | ﹤0.01% | 3255 |
|
|
2020
Q4 | $3.61M | Sell |
21,588
-58
| -0.3% | -$9.59K | ﹤0.01% | 3121 |
|
|
2020
Q3 | $3.34M | Buy |
21,646
+3,267
| +18% | +$470K | ﹤0.01% | 2982 |
|
|
2020
Q2 | $2.72M | Buy |
18,379
+3,408
| +23% | +$468K | ﹤0.01% | 3059 |
|
|
2020
Q1 | $1.69M | Sell |
14,971
-80,566
| -84% | -$10.5M | ﹤0.01% | 3125 |
|
|
2019
Q4 | $13.3M | Buy |
95,537
+86,185
| +922% | +$9.57M | ﹤0.01% | 2380 |
|
|
2019
Q3 | $901K | Buy |
9,352
+352
| +4% | +$39.3K | ﹤0.01% | 3418 |
|
|
2019
Q2 | $1.04M | Buy |
+9,000
| New | +$1.08M | ﹤0.01% | 3415 |
|
|
2018
Q3 | – | Sell |
-13,755
| Closed | -$915K | – | 3771 |
|
|
2018
Q2 | $915K | Sell |
13,755
-968
| -7% | -$63.7K | ﹤0.01% | 3412 |
|
|
2018
Q1 | $963K | Sell |
14,723
-3,735
| -20% | -$210K | ﹤0.01% | 3346 |
|
|
2017
Q4 | $739K | Sell |
18,458
-294
| -2% | -$10.7K | ﹤0.01% | 3397 |
|
|
2017
Q3 | $679K | Buy |
+18,752
| New | +$538K | ﹤0.01% | 3439 |
|
Other funds holding ASND
RCM
ACA
